Skip to content
ESE logo
Upcoming calls

This page provides links to a selection of upcoming calls from the Horizon Europe and other European programmes. These have been selected by the ESE Science Committee as calls that are likely to have relevance to endocrinologists.

Upcoming Cluster 1 Health Calls

Upcoming  Cluster 1 Health Calls

HORIZON-HLTH-2024-CARE-14-01: Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems

HORIZON-HLTH-2024-DISEASE-13-01: Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)

  • Both calls opened on 25 April 2024 with deadline on 26 November 2024

There are also  following CSA and CoFund calls. They are aimed at research funders, policy makers, government departments and  are not aimed at researchers.

  • HORIZON-HLTH-2024-DISEASE-17-01: Pandemic preparedness and response: Maintaining and enhancing the preparatory work for a co-funded European partnership for pandemic preparedness
  • HORIZON-HLTH-2024-DISEASE-12-01: European partnership for pandemic preparedness
  • HORIZON-HLTH-2024-DISEASE-09-01: European Partnership: One Health AntiMicrobial Resistance


Mission Cancer

Mission Cancer has launched its new calls for 2024, with a total budget of 119 M€. All calls opening: 18 Apr 2024 with deadlines on 18 Sep 2024

The calls are the following

HORIZON-MISS-2024-CANCER-01-01: Use cases for the research data platform

HORIZON-MISS-2024-CANCER-01-02: Support dialogue towards the development of national cancer data nodes

HORIZON-MISS-2024-CANCER-01-03: Accessible and affordable tests to advance early detection of heritable cancers in European regions

HORIZON-MISS-2024-CANCER-01-04: Support a pragmatic clinical trial programme by cancer charities

HORIZON-MISS-2024-CANCER-01-05: Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer


MSCA calls

The European Commission has announced new calls under the Marie Skłodowska-Curie Actions (MSCA) in 2024. This year, the MSCA will provide organisations with over €1.25 billionto fund cutting-edge research through excellent doctoral and postdoctoral programmes, collaborative research and innovation projects and research fellowships.

MSCA Postdoctoral Fellowships 2024

Opening date 23 April 2024

Deadline date 11 September 202



Opening date 23 April 2024

Deadline date 26 September 2024


MSCA Staff Exchanges 2024

Planned opening date 10 October 2024

Deadline date 05 March 2025


MSCA Researchers at Risk 2024

Planned opening date 12 September 2024

Deadline date 14 January 202


MSCA Doctoral Networks 2024

Planned opening date 29 May 2024

Deadline date 27 November 2024


European Research Council Calls 2024

  Call   Identifier   Call Opens   Deadline Date
 ERC Advanced Grant  ERC-2024-AdG 29 May 2024  29 Aug 2024 
 ERC Proof of Concept (only for ERC Grant holders)  ERC-2024-PoC 16 Nov 2023  I 14 Mar 2024; II 17 Sep 2024 

For more information, please consult the ERC Workprogramme 2024 (PDF).

The Innovative Health Initiative (IHI)

Innovative Health Initiative (IHI) is a partnership for health research and innovation between the EU (funded through Horizon Europe) and Europe's life science industries. Scientists from academia, diverse industry sectors, SMEs, mid-sized companies, hospitals and patients’ organisations are encouraged to get involved. The IHI holds regular calls for proposals.

The IHI has published its 2024 Work Programme and has launched Call 6 and 7

Call 6 topics:

Call 6 invites  two stage applications with first stage deadline on 16 April 2024 and  full proposal submission deadline: 10 October 2024.

Call 7 topics

Full proposal submission deadline: 22 May 2024

The IHI organised a series of info and pitching sessions on Call 6 and Call 7 , and there is also an online brokerage platform

Find out more 

Global Health European and Developing Countries Clinical Trials Partnership  (GH EDCTP3)

The GH EDCTP3 partnership funds collaborative clinical research on medicinal products and supports the capacity for sub-Saharan African countries to conduct high-quality clinical studies

GH EDCTP3  recently published their Work Programme for 2024.. There are seven 2024 call topics worth €140m, with a first stage deadline of 4 April 2024, second stage 12 September 2024

The calls are following:

For more information please see and presentation from call information day

European Partnership for Personalised Medicine (EP PerMed) Launched including First Call

The European Partnership for Personalised Medicine has been launched and follows on from the ICPerMed project. EP PerMed aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. It has a total budget of around €375 million provided by the EU (from Horizon Europe) and more than 50 partners (that are mainly funding organisations from Europe and beyond). EP PerMed will not only significantly support the transnational development of personalised medicine approaches over the next ten years, but also their successful translation into clinical practice.

Because EP PeMed is a co-funded partnership, it does not follow the normal Horizon Europe eligibility and funding rules - potential applicants should check on a call by call basis to see which countries and types of organisation are eligible for funding.

EP PerMed has announced its first call for proposals "Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)" with deadline for pre-proposal submission on 5 March 2024 and deadline for full-proposal submission on 20 June 2024.

The European Partnership on transforming health and care systems (THCS) - Pre-Announcement of The Second Joint Transnational Call

THCS is  a Cofund action under the Horizon Europe Programme  designed to support coordinated national and regional research and innovation programmes along with capacity building, networking, dissemination and other key activities to support health and care systems transformation.

Second Joint Translational  call aims to support the implementation of innovative person-centred health and care models addressing prevention strategies, with the key help of existing IT and digital technologies and services.


February 20, 2024

Publication of the call

March, 2024

JTC2024 Information day for applicants

April 16, 2024

Deadline for submission of Intent to Apply

May 14, 2024

Deadline for submission of proposals

For more information please refer to relevant THCS webpage

European Joint Programme on Rare Diseases

HORIZON-CL4-2024-RESILIENCE-01-36 Advanced biomaterials for the Health Care (IA) - two stage call - I deadline 07 February 2024, II deadline 24 September 2024